Cargando…
The Role of Inflammatory Proteins in Anti-Glucocorticoid Therapy for Treatment-Resistant Depression
Background: Optimising treatments for patients with treatment-resistant depression (TRD) is key to reducing the burden of this severe illness. The anti-glucocorticoid medication metyrapone has mixed evidence supporting a role as a possible augmentation treatment in TRD. The degree of treatment resis...
Autores principales: | Strawbridge, Rebecca, Jamieson, Alzbeta, Hodsoll, John, Ferrier, Ian Nicol, McAllister-Williams, Richard Hamish, Powell, Timothy R., Young, Allan H., Cleare, Anthony J., Watson, Stuart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920038/ https://www.ncbi.nlm.nih.gov/pubmed/33669254 http://dx.doi.org/10.3390/jcm10040784 |
Ejemplares similares
-
Associations between childhood maltreatment and inflammatory markers
por: Palmos, Alish B., et al.
Publicado: (2019) -
Growth Factor Proteins and Treatment-Resistant Depression: A Place on the Path to Precision
por: Pisoni, Alice, et al.
Publicado: (2018) -
A retrospective examination of care pathways in individuals with treatment-resistant depression
por: Day, Elana, et al.
Publicado: (2021) -
Biomarkers for depression: recent insights, current challenges and future prospects
por: Strawbridge, Rebecca, et al.
Publicado: (2017) -
Inflammatory Proteins and Clinical Response to Psychological Therapy in Patients with Depression: An Exploratory Study
por: Strawbridge, Rebecca, et al.
Publicado: (2020)